The abstract is read at the publisher; the summary is JClub's.
In 222 people with cystic fibrosis and normal glucose tolerance, each interquartile increase in 30-min C-peptide during OGTT is linked to lower incident CFRD hazard (HR 0.52, 95% CI 0.30–0.92).
- Why it matters: A validated risk tool is lacking for predicting cystic fibrosis-related diabetes in pwCF who start with normal glucose tolerance, limiting early identification.
- What they did: This multicenter retrospective cohort followed 309 pwCF from three Italian centers for a median 8.8 years, using time-varying Cox models on OGTT-derived beta-cell and insulin sensitivity markers, with bootstrap validation and grid-search threshold exploration.
- The result: CFRD occurred in 70/309 (22.7%), and while an exploratory 4.65 ng/mL (1.54 nmol/L) 30-min C-peptide cutoff separated risk groups, it was unstable under resampling, implying external validation is needed.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.